| 2025-12-19 |
详情>>
内部人交易：
Schwendenman Andrew等共交易5笔
|
| 2025-11-06 |
详情>>
股本变动：
变动后总股本7844.33万股
|
| 2025-11-06 |
详情>>
业绩披露：
2026年中报每股收益-1.85美元,归母净利润-1.7亿美元,同比去年增长-58.94%
|
| 2025-08-07 |
详情>>
业绩披露：
2026年一季报每股收益-0.95美元,归母净利润-8669.3万美元,同比去年增长-61.22%
|
| 2025-07-25 |
股东大会：
将于2025-09-03召开股东大会
会议内容 ▼▲
- 1.To elect Philip Astley-Sparke, Kapil Dhingra, Michael Goller, Christy Oliger and Joseph Slattery as Class I members of the Company’s Board of Directors (each a “Class I director”), each to serve for a three-year term until the Company’s 2028 Annual Meeting of Stockholders and until his or her respective successor is duly elected and qualified;
2.To ratify the selection of PricewaterhouseCoopers LLP as the independent registered public accounting firm for Replimune Group, Inc. for the fiscal year ending March 31, 2026.
3.To approve, on a non-binding advisory basis, the compensation of Replimune Group, Inc.’s named executive officers for the fiscal year ended March 31, 2025.
4.To approve an amendment to Replimune Group, Inc.’s 2018 Omnibus Incentive Compensation Plan (the “Plan Amendment”).
5.Consider and act upon any other matters that properly come before the Annual Meeting or any continuation, adjournment or postponement thereof.
|
| 2025-07-22 |
复牌提示：
2025-07-22 09:42:38 停牌，复牌日期 2025-07-22 09:52:38
|
| 2025-05-22 |
详情>>
业绩披露：
2025年年报每股收益-3.07美元,归母净利润-2.47亿美元,同比去年增长-14.6%
|
| 2025-05-22 |
财报披露：
美东时间 2025-05-22 盘前发布财报
|
| 2025-02-12 |
详情>>
业绩披露：
2025年三季报(累计)每股收益-2.25美元,归母净利润-1.73亿美元,同比去年增长-7.75%
|
| 2024-11-12 |
详情>>
业绩披露：
2025年中报每股收益-1.45美元,归母净利润-1.07亿美元,同比去年增长2.53%
|
| 2024-08-08 |
详情>>
业绩披露：
2025年一季报每股收益-0.78美元,归母净利润-5377.2万美元,同比去年增长-8.51%
|
| 2024-07-19 |
股东大会：
将于2024-09-04召开股东大会
会议内容 ▼▲
- 1.To elect Sushil Patel, Dieter Weinand, and Madhavan Balachandran as Class III members of Replimune’s Board of Directors (each a “Class III director”), each to serve for a three-year term until Replimune’s 2027 Annual Meeting of Stockholders and until his respective successor is duly elected and qualified;
2.To ratify the selection of PricewaterhouseCoopers LLP as the independent registered public accounting firm for Replimune for the fiscal year ending March 31, 2025;
3.To approve, on a non-binding advisory basis, the compensation of the Company’s named executive officers as disclosed in the enclosed proxy statement;
4.To approve, on a non-binding advisory basis, the preferred frequency of future advisory votes on the compensation of the Company’s named executive officers.
|
| 2024-05-16 |
详情>>
业绩披露：
2024年年报每股收益-3.24美元,归母净利润-2.16亿美元,同比去年增长-23.82%
|
| 2024-02-08 |
详情>>
业绩披露：
2024年三季报(累计)每股收益-2.42美元,归母净利润-1.61亿美元,同比去年增长-28.53%
|
| 2023-11-07 |
详情>>
业绩披露：
2024年中报每股收益-1.65美元,归母净利润-1.1亿美元,同比去年增长-28.4%
|
| 2023-08-03 |
详情>>
业绩披露：
2024年一季报每股收益-0.75美元,归母净利润-4955.5万美元,同比去年增长-17.28%
|
| 2023-07-26 |
股东大会：
将于2023-09-06召开股东大会
会议内容 ▼▲
- 1.To elect Paolo Pucci and Veleka Peeples-Dyer as Class II members of Replimune’s Board of Directors (each a “Class II director”), each to serve for a three-year term until Replimune’s 2026 Annual Meeting of Stockholders and until his or her respective successor is duly elected and qualified;
2.To ratify the selection of PricewaterhouseCoopers LLP as the independent registered public accounting firm for Replimune for the fiscal year ending March 31, 2024.
|
| 2022-07-27 |
股东大会：
将于2022-09-07召开股东大会
会议内容 ▼▲
- 1.To elect Philip Astley-Sparke, Kapil Dhingra, Christy Oliger and Joseph Slattery as Class I members of Replimune’s Board of Directors (each a “Class I director”), each to serve for a three-year term until Replimune’s 2025 Annual Meeting of Stockholders and until his or her respective successor is duly elected and qualified;
2.To ratify the selection of PricewaterhouseCoopers LLP as the independent registered public accounting firm for Replimune for the fiscal year ending March 31, 2023.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-07-22 |
股东大会：
将于2021-09-08召开股东大会
会议内容 ▼▲
- 1.To elect Robert Coffin, Hyam Levitsky and Dieter Weinand as Class III members of Replimune’s Board of Directors (each a “Class III director”), each to serve for a three-year term until Replimune’s 2024 Annual Meeting of Stockholders and until his respective successor is duly elected and qualified; 2.To ratify the selection of PricewaterhouseCoopers LLP as the independent registered public accounting firm for Replimune for the fiscal year ending March 31, 2022.
|
| 2020-07-29 |
股东大会：
将于2020-09-09召开股东大会
会议内容 ▼▲
- 1.To elect Paolo Pucci, Jason Rhodes, Sander Slootweg, and Otello Stampacchia as Class II members of Replimune's Board of Directors (each a "Class II director"), each to serve for a three-year term until Replimune's 2023 Annual Meeting of Stockholders and until his respective successor is duly elected and qualified;
2.To ratify the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for Replimune for the fiscal year ending March 31, 2021.
|
| 2019-08-09 |
股东大会：
将于2019-09-04召开股东大会
会议内容 ▼▲
- 1.To elect Philip Astley-Sparke, Kapil Dhingra, and Joseph Slattery as Class I members of the Company's Board of Directors (each a "Class I director"), each to serve for a three-year term until the Company's 2022 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified;
2.To amend the Company's certificate of incorporation to remove the exclusive federal forum clause and make certain amendments to the exclusive Delaware forum clause;
3.To ratify the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for the Company for the fiscal year ending March 31, 2020.
|